BRTX vs J · rev $401.0K vs P/E 36, $14.40B cap
BioRestorative Therapies Inc (BRTX) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
J does not have a complete income-statement cache yet.
BRTX currently screens at market cap $10.2M. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the BRTX and J stock pages for the full models.
Not investment advice.